Cargando…
ACBP/DBI protein neutralization confers autophagy-dependent organ protection through inhibition of cell loss, inflammation, and fibrosis
Acyl-coenzyme A (CoA)–binding protein (ACBP), also known as diazepam-binding inhibitor (DBI), is an extracellular feedback regulator of autophagy. Here, we report that injection of a monoclonal antibody neutralizing ACBP/DBI (α-DBI) protects the murine liver against ischemia/reperfusion damage, into...
Autores principales: | Motiño, Omar, Lambertucci, Flavia, Anagnostopoulos, Gerasimos, Li, Sijing, Nah, Jihoon, Castoldi, Francesca, Senovilla, Laura, Montégut, Léa, Chen, Hui, Durand, Sylvère, Bourgin, Mélanie, Aprahamian, Fanny, Nirmalathasan, Nitharsshini, Alvarez-Valadez, Karla, Sauvat, Allan, Carbonnier, Vincent, Djavaheri-Mergny, Mojgan, Pietrocola, Federico, Sadoshima, Junichi, Maiuri, Maria Chiara, Martins, Isabelle, Kroemer, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9565466/ https://www.ncbi.nlm.nih.gov/pubmed/36191214 http://dx.doi.org/10.1073/pnas.2207344119 |
Ejemplares similares
-
Antibody-mediated neutralization of ACBP/DBI has anorexigenic and lipolytic effects
por: Sica, Valentina, et al.
Publicado: (2020) -
DBI/ACBP is a targetable autophagy checkpoint involved in aging and cardiovascular disease
por: Montégut, Léa, et al.
Publicado: (2022) -
Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index
por: Joseph, Adrien, et al.
Publicado: (2021) -
High plasma concentrations of acyl‐coenzyme A binding protein (ACBP) predispose to cardiovascular disease: Evidence for a phylogenetically conserved proaging function of ACBP
por: Montégut, Léa, et al.
Publicado: (2022) -
Correction: An obesogenic feedforward loop involving PPARγ, acyl-CoA binding protein and GABA receptor
por: Anagnostopoulos, Gerasimos, et al.
Publicado: (2022)